POMDOCTOR Total Current Assets from 2010 to 2026

POM Stock   0.32  0.01  3.23%   
POMDOCTOR LIMITED Total Current Assets yearly trend continues to be very stable with very little volatility. Total Current Assets are likely to drop to about 41 M. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2003-03-31
Previous Quarter
47.8 M
Current Value
37.5 M
Quarterly Volatility
4.4 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check POMDOCTOR LIMITED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among POMDOCTOR LIMITED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 147 K, Interest Expense of 14.2 M or Total Revenue of 374.2 M, as well as many indicators such as Price To Sales Ratio of 13.42, Dividend Yield of 0.0 or Days Sales Outstanding of 19.31. POMDOCTOR financial statements analysis is a perfect complement when working with POMDOCTOR LIMITED Valuation or Volatility modules.
  
Build AI portfolio with POMDOCTOR Stock
Check out the analysis of POMDOCTOR LIMITED Correlation against competitors.

Latest POMDOCTOR LIMITED's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of POMDOCTOR LIMITED American over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. POMDOCTOR LIMITED's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in POMDOCTOR LIMITED's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Pretty Stable
   Total Current Assets   
       Timeline  

POMDOCTOR Total Current Assets Regression Statistics

Arithmetic Mean2,741,312,018
Geometric Mean433,879,185
Coefficient Of Variation172.13
Mean Deviation3,456,713,406
Median1,084,000,000
Standard Deviation4,718,509,550
Sample Variance22264332.4T
Range13.3B
R-Value(0.21)
Mean Square Error22702664.9T
R-Squared0.04
Significance0.42
Slope(196,097,622)
Total Sum of Squares356229318T

POMDOCTOR Total Current Assets History

202641 M
202543.1 M
202437.5 M
202359.4 M
202247.7 M
202118.4 M
202026.1 M

About POMDOCTOR LIMITED Financial Statements

POMDOCTOR LIMITED investors utilize fundamental indicators, such as Total Current Assets, to predict how POMDOCTOR Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Assets43.1 M41 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether POMDOCTOR LIMITED is a strong investment it is important to analyze POMDOCTOR LIMITED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact POMDOCTOR LIMITED's future performance. For an informed investment choice regarding POMDOCTOR Stock, refer to the following important reports:
Check out the analysis of POMDOCTOR LIMITED Correlation against competitors.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Pharmaceutical Retailers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of POMDOCTOR LIMITED. If investors know POMDOCTOR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about POMDOCTOR LIMITED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of POMDOCTOR LIMITED is measured differently than its book value, which is the value of POMDOCTOR that is recorded on the company's balance sheet. Investors also form their own opinion of POMDOCTOR LIMITED's value that differs from its market value or its book value, called intrinsic value, which is POMDOCTOR LIMITED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because POMDOCTOR LIMITED's market value can be influenced by many factors that don't directly affect POMDOCTOR LIMITED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between POMDOCTOR LIMITED's value and its price as these two are different measures arrived at by different means. Investors typically determine if POMDOCTOR LIMITED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, POMDOCTOR LIMITED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.